Back to Search
ANNA ROSENQUIST, MD
MD
Pediatrics Physician
NPI: 1922134758Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
L-225251(MA)
Research & Publications (18)
Design and synthesis of BACE-1 inhibitors utilizing a tertiary hydroxyl motif as the transition state mimic.
PMID 19576765·Bioorg Med Chem Lett·2009
8-other
In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor.
PMID 19171797·Antimicrob Agents Chemother·2009
7-preclinical
Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors.
PMID 18954982·Bioorg Med Chem Lett·2008
7-preclinical
Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350.
PMID 18678486·Bioorg Med Chem Lett·2008
4-observational
Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza.
PMID 17403845·Pediatrics·2007
8-other
Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors.
PMID 17307552·J Pediatr·2007
8-other
Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
PMID 16675222·Bioorg Med Chem·2006
8-other
Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II.
PMID 15974592·J Med Chem·2005
7-preclinical
Symmetric fluoro-substituted diol-based HIV protease inhibitors. Ortho-fluorinated and meta-fluorinated P1/P1'-benzyloxy side groups significantly improve the antiviral activity and preserve binding efficacy.
PMID 15560801·Eur J Biochem·2004
8-other
Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs.
PMID 15189032·J Med Chem·2004
7-preclinical
Noradrenergic mechanisms in neurodegenerative diseases: a theory.
PMID 15063099·Brain Res Brain Res Rev·2004
6-review
New inhibitors of the malaria aspartyl proteases plasmepsin I and II.
PMID 12878137·Bioorg Med Chem·2003
7-preclinical
Synthesis and Biological activity of kappa opioid receptor agonists. Part 2: preparation of 3-aryl-2-pyridone analogues generated by solution- and solid-phase parallel synthesis methods.
PMID 12643930·Bioorg Med Chem Lett·2003
8-other
Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II.
PMID 12614868·Bioorg Med Chem·2003
7-preclinical
3-Aryl pyridone derivatives. Potent and selective kappa opioid receptor agonists.
PMID 11755353·Bioorg Med Chem Lett·2002
8-other
Ibotenic acid lesions in the pedunculopontine region result in recovery of visual orienting in the hemianopic cat.
PMID 11682162·Neuroscience·2001
7-preclinical
Optimization of a somatostatin mimetic via constrained amino acid and backbone incorporation.
PMID 11133079·Bioorg Med Chem Lett·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20 WALL ST
BURLINGTON, MA 01803 - Phone
- (781) 221-2800
Quick Facts
- NPI
- 1922134758
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile